Nick Mordwinkin
Corporate Officer/Principal chez KEZAR LIFE SCIENCES, INC.
Fortune : - $ au 30/04/2024
Profil
Nick Mordwinkin was the founder of Curium, a company founded in 2014, where he held the title of President from 2014 to 2016.
He is currently the Chief Business Officer at Kezar Life Sciences, Inc. since 2022.
Previously, he worked at Ultragenyx Pharmaceutical, Inc. from 2015 to 2020 as the Senior Director & Head-Corporate Strategy.
From 2020 to 2022, he was the Head-Development, Inflammation & Fibrosis at Gilead Sciences, Inc. Dr. Mordwinkin holds a doctorate degree from the University of Southern California and an undergraduate degree from Nova Southeastern University, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Nick Mordwinkin
| Sociétés | Poste | Début |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 11/07/2022 |
Anciens postes connus de Nick Mordwinkin
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/10/2020 |
| Curium | Fondateur | 01/12/2016 |
Formation de Nick Mordwinkin
| Nova Southeastern University, Inc. | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Curium |